Biochemical Engineering


Hub Users

The Future Targeted Healthcare Manufacturing Hub’s research is supported by a User Steering Committee of over 35 industrial users and sector organisations to revolutionise the delivery of cost-effective stratified protein-based and personalised cell-based therapies to patients. The Hub User Steering Committee provides advice and guidance on the overall direction and progress of the Hub research.

The Hub User Steering Committee has 5 Specialist Working Groups (SWGs) to provide more detailed advice and direction on specific elements of the research:

  • Decisional tools
  • Cell-free synthesis
  • T-cell processing
  • Formulation
  • Healthcare

Hub User Steering Committee Members*:

hub logos september 2018

Companies: Aglaris, Albumedix, Allergan, AstraZenica/MedImmune, Autolus, BIA Separations, Biologic B, BioPharm Services, deltaDOT, Eli Lilly, Francis BioPharm Consulting, Fujifilm Diosynth Biotechnologies, GSK, Ipsen, Lonza, Oracle, Oxford BioMedica, Pall, Perceptive, Puridify, Purolite,Rare Access, ReNeuron, Sartorius, SSC Bio, Sutro BioPharma, Tillingbourne Consulting, TrakCel, West Pharma, Wyatt

Industry/Govt Associations: ABPI, BIA, KTN, LGC, MMIP, NIBSC

Translational Spokes: Cell and Gene Therapy Catapult, Centre for Process Innovation/NBMC  

* Signed or in the process of signing the Collaboration agreement as of September 2018